DEAR MAYO CLINIC: I have dealt with digestive issues for much of my 30s. Ulcers run in my family. My doctor said that while I could have an ulcer, testing could determine if it is functional dyspepsia ...

A small, randomized, double-blind, placebo-controlled trial in Thailand suggests that turmeric has comparable efficacy to omeprazole for treating functional dyspepsia. The researchers randomly ...

Please provide your email address to receive an email when new articles are posted on . CHARLOTTE, N.C. — Virtual reality significantly improved symptoms and quality of life in a small subset of ...

Commonly prescribed medicines, particularly painkillers and certain antibiotics, may trigger dyspepsia symptoms in children, according to findings from the EMPACIP study on drug-induced dyspepsia ...

Please provide your email address to receive an email when new articles are posted on . Both hypnotherapy and medical treatment, in combination with psychological support, reduced symptoms of chronic ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Improvements in ...

LANDING, N.J., June 14, 2021 /PRNewswire/ — DolCas Biotech, LLC’s award-winning patented ingredient, GinfortTM, has shown significant potential for reducing a broad range of functional ...

CARMEL, Ind., Oct. 24, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

A virtual reality headset using software consisting of passive and active immersive 3D audiovisual programs improved symptoms and quality of life for patients with functional dyspepsia, a randomized ...

Achieves significant expansion of NeurAxis’ total addressable market Clearance now includes patients aged “8 years and older” Expanded age indication will utilize the upcoming January 1 st, 2026, ...